Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04959825Phase 1Completed
Phase 1, randomised, double-blind trial of melatonin in pain (2 arms), sponsored by Cairo University. Primary endpoint: Inhaled isoflurane requirement to maintain entropy readings 40-60 at 2 hours. Started Jul 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04959825.